L44: Cancer Biochemistry I-II Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

List the six acquired capabilities of cancer cells

A
  • Self-sufficiency in growth signals - Insensitivity to anti-growth signals - Evading apoptosis - Limitless replicative potential - Sustained angiogenesis - Tissue invasion and metastasis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define proto-oncogene. How does mutation in these genes contribute to development of cancer?

A
  • Proto-oncogene: promote cell growth - Loss of function causes excessively active growth promotion = stuck accelerator = oncogene = typically dominant mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define tumor suppressor. How does mutation in these genes contribute to development of cancer?

A
  • Tumor suppressor: inhibit cell growth - Loss of function relieves growth inhibition = non-functioning brake pedal, typically recessive mutations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define caretaker gene. How does mutation in these genes contribute to development of cancer?

A
  • Caretaker genes: maintain integrity of genes (mismatch repair etc.) - Loss of function allows mutations to accumulate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe how the receptor tyrosine kinases HER2 and ErbB1 can be converted into constitutively active forms that function as oncoproteins

A
  • HER2 (aka Neu): point mutation allows activation of kinase in the absence of ligand - ErbB1: deletion of ligand bind domain results in constitutive activation of kinase domain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Outline the Ras/MAP kinase pathway and describe how mutant forms of Ras can contribute to the development of cancer.

A
  • Mutations at AA 12, 13 and 61 cause Ras protein that favors GTP binding and therefore an activated form of Ras. - As a result, Ras signaling through Ras/MAP kinase pathway will occur irrespective of ligand binding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Burkitt’s Lymphoma? Describe biochemistry that causes it.

A
  • Translocation event moves c-myc gene from normal position on c/s #8 over to c/s #14 - Result = myc gene is now near control elements of antibody HC and continuous production of high levels of Myc occurs in B-cells. B-cells become cancerous
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the two hit model? Describe this model in relation to the development of retinoblastoma. What is the normal function of Rb?

A
  • Tumor suppressor genes inhibit proliferation - Damage to both alleles must occur to allow unregulated proliferation as the genes are recessive - This is why it is called two hit model - Individuals inheriting one mutant allele of tumor suppressor gene are at increased risk for certain cancers. If somatic mutation in second allele, tumor growth will occur Retinoblastoma mutation: - Rb protein is phosphorylated by cyclin D-CDK4/6 or cyclin E-CDK2. When phosphorylated, drives cell cycle. - Inherited form: one mutant allele from parent, somatic mutation of second allele in retinal cell leads to retinoblastoma. Tumor tends to develop in infancy - Sporadic form: two separate somatic mutations in a retinal cell or its progeny produces retinal cell in which both copies of functional Rb are lost - Symptoms: Leukocoria = white pupil, represents calcified intraorbital masses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe role of p53 in triggering cell cycle arrest or apoptosis in response to DNA damage. What gene encodes it?

A
  • p53 is normally an unstable protein, is ubiquinated and destroyed by proteasome when not stabilized - Phosphorylation by ATM/ATR (double-stranded breaks or UV damage respectively) increases stability of it, which leads to transcriptional control of many genes that regulate cell cycle arrest, repair of DNA and apoptosis - Encoded by gene TP53 - Active p53 is homotetramer. Missense mutations in one allele greatly reduce function. Any subunit mutation of the tetramer will cause aberrant function. Mutations act as dominant negative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Li-Fraumeni syndrome?

A
  • Dominant heritable condition conferring increased susceptibility to many forms of cancer as a result of dominant negative effect of mutation to TP53 allele - Cells with damaged DNA are free to continue to divide and tumors develop
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe biochemistry behind HPV-induced cervical cancer

A
  • HPV virus produces E6 and E7 proteins that target p53 and Rb respectively leading to ubiqutination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is neurofibromatosis I? What is normal function of the protein?

A
  • Symptoms/signs: café au lait spots, multiple non-malignant peripheral nerve tumors (neurofibromas) and iris Lisch nodules - Result of loss of function mutation in NF1 gene (recessive) that encodes neurofibromin that normally accelerates rate of GTP hydrolysis by Ras, causing it to be in inactive form - Lack of NF1 gene function prolongs Ras signaling increases proliferation through MAP kinase pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Examples of caretaker genes. Cancers resulting in defects from these genes

A
  • MSH2 or MLH1 code for DNA mismatch repair. Mutations lead to HNPCC: hereditary nonpolyposis colorectal carcinoma - BRCA1 or BRCA2 gene code for machinery involved in homologous recombination. Mutations lead to increased risk of breast/ovarian and cancer development. Unable to repair of double-stranded DNA breaks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can epigenetic changes contribute to the development of cancers? Example

A
  • Increased methylation silences transcription of a gene, reducing tumor suppressor expression - Decreased methylation activates transcription of a gene, increasing production of oncoprotein - Example: INK4 promoter methylation suppresses transcription, preventing p16ink4 synthesis, allowing for continued phosphorylation of Rb by cyclin-D:CDK4/6 and cell proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe the breakage/fusion/bridge cycle that can occur in cells where there is damage to the cell cycle checkpoints.

A
  • Loss of p53 function prevents ability for cell cycle to arrest - Result = breakage/fusion/bridges in genetic material result in large amount of genetic rearrangement - Normally cells die as a result of this - In the case of cancer, re-expression of telomerase allows cells to continue one with significantly altered DNA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is HIF-1alphabeta and how is it regulated? What is the importance of HIF-1alphabeta in the growth of tumors?

A
  • In normoxic environment, HIF-1alpha (hypoxia-inducible-factor) is hydroxylated by proline hydroxylase, leading to accumulation and destruction of itself - In hypoxic environment, HIF-1alpha associates with HIF-1beta, which regulates expression of VEGF and many other genes, allowing for angiogenesis to proceed. - Result = new blood supply delivers nutrients/oxygen, removes waste to/from tumors
17
Q

Outline the steps that must occur before an epithelial cell tumor can form metastases.

A
  • Adhesions bw cells are mediated by E-cadherin. CA cells must break this down - CA cells secrete enzymes called MMPs (matrix metalloproteases) that attack basement membrane - CA cells are stimulated by binding proteolytic fragments of collage IV and laminin - CA cells move into and through ECM - CA cells degrade vascular BM and enter circulation through process known as intravasation - Some CA cells are destroyed by immune system, some exit circulation and find new “home” by extravasation
18
Q

What is connection between primary tumor site and site of extravasation?

A
  • Anatomical connection at the site of extravasation
19
Q

What is familial adenomatous polyposis? Outline the role of APC in the WNT signaling pathway. How does loss of APC function lead to cell proliferation?

A
  • Hereditary condition due to mutations in APC (adenomatous polyposis coli) gene that encodes tumor suppressor APC. Develop 100-1000s of adenomatous polyps. 100% of untreated FAP pts developed colorectal adenocarcinomas. Prophylactic colectomy is done - APC usually functions to down-regulate WNT signaling pathway - When mutation exists, WNT signaling is activated and expression of cyclin D, Myc and other growth-promoting genes occur - Additional mutations are implicated: oncogenic forms of Ras, may impact p53 function
20
Q

Outline the changes that must occur before normal cells of the colon can develop into an adenoma and then a carcinoma.

A
  • FAP pts inherit one defective allele from parent - Inactivation/loss of second allele occurs = - Proto-oncogene mutation, typically in Ras and loss of tumor suppressor genes typically TP53 causes adenomas - Additional mutations, gross c/smal changes, increased telomerase leads to carcinoma
21
Q

What is familial nonpolyposis colorectal carcinoma (HNPCC; Lynch syndrome)? Which genes are generally mutated in HNPCC? Which DNA repair pathway is impacted?

A
  • Hereditary susceptibility to colon cancer, 80% lifetime risk of colorectal carcinoma - Arises from defect in DNA mismatch repair (mutations to MSH2 or MLH1) genes - Pt inherits one defective allele from parent, loss or inactivation of second copy results in accumulation of mutations at accelerated rate typically in microsatellite repeats, which means microsatellite instability occurs - Microsatellite instability can reduce Bax protein function, which suppresses apoptosis and abnormal cells survive
22
Q

What is CML and what is the biochemistry behind it? What gene fusion is generated? What is the biochemical activity associated with the fusion protein? Treatment?

A
  • CML = chronic myelogenous leukemia - Result of translocation bw c/s 9 and 22, fuses the ABL gene usually on 9 to the BCR gene on 22, creating Philadelphia chromosome BCR-ABL on 22 - Result = constitutively active Bcr-Abl kinase can phosphorylate many targes. In hematopoietic cells, stimulates expansion of white blood cells - Treatment = imatinib mesylate (Gleevec) is specific inhibitor of this kinase
23
Q

What is the target of the drug trastuzumab (Herceptin) used in the treatment of some breast cancers?

A
  • Binds to EC domain of Her2/Neu and is important inhibitor of tumor growth. - Mechanism? Inhibition of receptor dimerization and activation, induction of apoptosis, stimulation of antibody or complement-mediated cytotoxicity